FAKTOR-OPTIONSSCHEIN - COOPER COMPANIES Share Price

Certificat

DE000ME4U8B4

Market Closed - Börse Stuttgart 01:08:47 18/05/2024 am IST
10.57 EUR -10.20% Intraday chart for FAKTOR-OPTIONSSCHEIN - COOPER COMPANIES
Current month+72.43%
1 month+51.87%
Date Price Change
17/24/17 10.57 -10.20%
16/24/16 11.77 +23.25%
15/24/15 9.55 +25.49%
14/24/14 7.61 -4.04%
13/24/13 7.93 -16.70%

Delayed Quote Börse Stuttgart

Last update May 18, 2024 at 01:08 am IST

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying THE COOPER COMPANIES, INC.
Issuer Morgan Stanley
WKN ME4U8B
ISINDE000ME4U8B4
Date issued 06/12/2023
Strike 85.68 $
Maturity Unlimited
Parity 1 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 24.24
Lowest since issue 5.72

Company Profile

The Cooper Companies, Inc. is a global medical device company. The Company operates through two business units: CooperVision and CooperSurgical. CooperVision is engaged in the contact lens industry. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys, Biofinity toric & Biofinity XR toric, Biofinity multifocal, Biofinity toric multifocal, clariti 1 day, clariti 1 day toric, clariti 1 day multifocal, MiSight 1 day, Avaira Vitality and Avaira Vitality toric. CooperSurgical is a fertility and women’s health company dedicated to assisting women, babies and families around the world. CooperSurgical provides a range of products and services with an emphasis on improving fertility solutions, empowering office-based care, and advancing hospital care within women’s health. CooperSurgical’s brands include Paragard, ER-Complete, Fetal Pillow, INSORB, PGT-Complete, RUMI II and others.
Sector
-
More about the company

Ratings for The Cooper Companies, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: The Cooper Companies, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
97.31 USD
Average target price
107.9 USD
Spread / Average Target
+10.87%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW